ARTICLE | Clinical News
Xultophy insulin degludec/liraglutide: Additional Phase IIIb data
September 21, 2015 7:00 AM UTC
Additional data from the open-label, international Phase IIIb DUAL V trial in 557 Type II diabetics uncontrolled on Lantus insulin glargine showed that once-daily Xultophy as an add-on to metformin s...